<HashMap><database>EGA</database><scores/><additional><omics_type>Genomics</omics_type><dataset_type>N/A</dataset_type><full_dataset_link>https://ega-archive.org/datasets/EGAD00001008800</full_dataset_link><sample_count>603</sample_count><description>EGA dataset EGAD00001008800</description><repository>EGA</repository><title>low pass WGS of patient from the CN300 cohort</title></additional><is_claimable>false</is_claimable><name>7a528f9b-17a4-406c-9542-1a49d3e676f5 - samples</name><description>We copy number profiled 688 tumor regions from 300 patients presenting with advanced prostate cancer and prospectively followed-up (median, 7 years) in the control group of the STAMPEDE trial. Patients were categorised into four metastatic states, namely high-risk non-metastatic (with or without local lymph node involvement) or metastatic (low or high volume).</description><dates><updated>2022-06-02 10:22:43</updated></dates><accession>EGAD00001008800</accession><cross_references><TAXONOMY>9606</TAXONOMY><EGA>EGAC00001002659</EGA><EGA>EGAS00001006251</EGA></cross_references></HashMap>